Working… Menu
Trial record 1 of 1 for:    mRNA-1644 | HIV
Previous Study | Return to List | Next Study

A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05001373
Recruitment Status : Recruiting
First Posted : August 11, 2021
Last Update Posted : December 3, 2021
ModernaTX, Inc.
The University of Texas at San Antonio
George Washington University
Fred Hutchinson Cancer Research Center
Emory University
Information provided by (Responsible Party):
International AIDS Vaccine Initiative

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 11, 2023
Estimated Study Completion Date : April 11, 2023